ArticleJournal for immunotherapy of cancer2024

Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases.

Chandra C Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.